John P. Schmid, Director at Xeris Biopharma Holdings, Inc. (XERS), bought 6,500 shares at $1.51 ($10K) on 2023-11-16, disclosed to the SEC on 2023-11-17.
Open-market purchase of $10k XERS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| XERS | BUY | 2024-08-13 | $10K | — | Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| XERS | BUY | 2024-05-10 | $10K | — | Filing → |